{"data":{"ModuleTitle":{"label":"Module Title","value":"Company Description"},"CompanyName":{"label":"Company Name","value":"Celldex Therapeutics, Inc."},"Symbol":{"label":"Symbol","value":"CLDX"},"Address":{"label":"Address","value":"53 FRONTAGE ROAD,SUITE 220, PERRYVILLE III BUILDING, HAMPTON, New Jersey, 08827, United States"},"Phone":{"label":"Phone","value":"+1 908 200-7500"},"Industry":{"label":"Industry","value":"Biotechnology: In Vitro & In Vivo Diagnostic Substances"},"Sector":{"label":"Sector","value":"Health Care"},"Region":{"label":"Region","value":"North America"},"CompanyDescription":{"label":"Company Description","value":"Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products targeting breast cancer, metastatic melanoma, lung cancer, solid tumors, and ovarian cancer. Its pipeline products are Varlilumab, CDX-301, CDX-1140,CDX-0159/Anti-KIT Program, and CDX-527."},"CompanyUrl":{"label":"Company Url","value":"https://www.celldex.com"},"KeyExecutives":{"label":"Key Executives","value":[{"name":"Anthony S. Marucci","title":"President, Chief Executive Officer & Director"},{"name":"Diane C. Young","title":"Chief Medical Officer & Senior Vice President"},{"name":"Tibor Keler","title":"Chief Scientific Officer & Executive VP"}]}},"message":null,"status":{"rCode":200,"bCodeMessage":null,"developerMessage":null}}